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SUMMARY
To assess the effects of both alcoholism and liver disease on gastroentero-
pancreatic hormones, fasting andpost-prandial concentrations were analysed in
thefollowingfourgroups: (1)Alcoholic subjects with liverdisease; (2)Alcoholic
subjects withoutliverdisease; (3) Controlsubjects with liverdisease; (4) Control
subjects without liver disease.
Liver disease was associated with increased fasting serum glucose, plasma
insulin, pancreatic polypeptide, gastrin and vasoactive intestinal polypeptide.
Alcoholism in the absence of liver disease did not influence either the fasting
or post-prandial concentrations of serum glucose, plasma gastrin, insulin,
pancreatic polypeptide, gastric inhibitory polypeptide, N- and C-terminal
glucagon or vasoactive intestinal polypeptide. Alcoholism with liver disease
depressed plasma gastric inhibitory polypeptide concentrations. The results
suggest that the abnormalities in gastroenteropancreatic hormone in alcoholics
are likely to be related to liver disease which is often concurrent.
INTRODUCTION
Alcohol is known to have widespread effects on the small intestine1 and chronic
alcohol abuse is often associated with liver disease.2 While there are a few studies
available which examine the effect of either alcoholism or liver disease on gastro-
enteropancreatic hormones,3 16 there are none which attempt to separate the
effects of alcoholism from the effects of the frequently concurrent liver disease
which in itself will distort the results due to decreased liver metabolism, blood
flow and porto-systemic shunting.
Accordingly, the aim ofthe present study was to assess fasting and post-prandial
concentrations of gastroenteropancreatic hormones in alcoholics and control
groups, both with and without liver disease. The four groups studied were:
(1) Alcoholics with liver disease (2) Alcoholics without liver disease (3) Patients
with non-alcoholic liver disease (4) Normal volunteers. From these four groups it
was hoped to draw conclusions regarding the effects of both alcoholism and liver
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disease on fasting and post-prandial glucose, and release of the gastroentero-
pancreatic hormones studied, which were gastrin, insulin, pancreatic polypeptide
(PP), gastric inhibitory polypeptide (GIP), glucagon N, glucagon C and vasoactive
intestinal polypeptide (VIP).
MATERIALS AND METHODS
Thirty-two alcoholic subjects (all less than 70 years), with alcohol consumption of
greater than 150g/day for five or more years, were divided into a group of 13
patients (12 male and one female) with liver disease, and a group of 19 patients
(18 male and one female) without liver disease. Of the 13 patients with liver
disease eight had a liver biopsy and the remaining five were diagnosed as having
liver disease on the basis of five to seven liver function tests which were greater
than three standard deviations from the mean, (increased serum gamma glutamyl
transferase, aspartate transaminase, alanine transaminase, alkaline phosphatase,
bilirubin, ora reduction intheprothrombin timeand serum pseudocholinesterase).
The 19 patients without liver disease had all liver function tests (including gamma
glutamyl transferase) and were within normal limits, (two standard deviations
from the mean). Patients with intermediate liver function tests were excluded
from the study. The study had approval ofthe Research Ethical Committee of the
Faculty of Medicine, The Queen's University of Belfast. Liver biopsy was not
performed on the 19 patients without evidence of liver disease. All alcoholic
patients had analcohol intake estimated fromtheirhistoryofalcohol consumption
during the previous five years and particularly during the preceding week.
Two control groups were used in the study. A group of 17 normal volunteers (14
male and three female) from the staff and students ofthe hospital, all less than 70
years old, were studied. They did not have any systemic illness, were on no
medication and their individual alcohol consumption was less than 1Og/day.
A further control group of 10 patients (six male and four female) with non-
alcoholic liver disease were studied. These patients, all of whom had a liver
biopsy, included three with primary biliary cirrhosis, three with chronic active
hepatitis, three with idiopathic cirrhosis and one with methotrexate-induced
cirrhosis.
Alcoholic patients were studied within 48 hours of admission to hospital. All
subjects were fasted overnight from 10 pm prior to study. At 9 pm on the day of
study each subject had an intravenous cannula secured in a forearm vein, and an
initial blood sample was taken for glucose and gastroenteropancreatic hormone
analysis. After 15 minutes a second fasting sample was taken from all subjects,
before a standardised meal was given. The meal used in this study consisted of
60g ham, 60g white bread, 15g butter, 100ml orange juice and one cup of tea.
This contained 50g carbohydrate, 18g protein and 20g fat and had an energy
value of450 kcalories. This meal was given at time 0 minutes and blood samples
were taken at times, 15, 30, 45, 60, 90 and 120 minutes. The cannula was
flushed out after each sample with physiological saline (0.9% NaC1). The first
3ml of each sample was discarded to prevent contamination with saline. All
hormone samples were immediately transferred to cooled heparinised tubes and
kept on ice before centrifugation at the end of the study. All blood samples were
analysed for glucose insulin, gastrin, gastric inhibitory polypeptide (GIP), and
pancreatic polypeptide (PP). In addition the fasting samples were analysed for
N-terminal glucagon, C-terminal glucagon and vasoactive intestinal polypeptide
(VIP). All hormones were analysed by radioimmunoassay using methods
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previously established in the Department of Medicine, The Queen's University of
Belfast.1720 The results were analysed non-parametrically using the Wilcoxon
rank sum test.
RESULTS
The mean age of the patients with alcoholic liver disease was 46 years (range
28-65 years); that of the patients without alcoholic liver disease 43 years (range
21-69 years); of those with non-alcoholic liver disease 57 years (range 21.69
years), and of the normal volunteers 45 years (range 19-69 years). There were
no significant differences between any of these groups.
The mean estimated daily alcohol consumption of the alcoholics with liver
disease was 235g/day (range 150-400g/day) and that of the alcoholics without
liver disease was 300g/day (range 150-750g/day) (N.S.). Only one patient with
non-alcoholic cirrhosis drank alcohol (10g/day). The mean alcohol consumption
in the normal volunteers was 5g/day (range 0-10g/day). The alcoholics with
liver disease had been drinking for a mean of 19 years (range 5-34 years) and the
alcoholics without liver disease had been drinking for a mean of 18 years (range
5-42 years).
Fasting gastroenteropancreatic hormone andglucose analysis
The results of fasting gastroenteropancreatic hormone and glucose analysis are
presented in the Table. These fasting results are the average of the two fasting
samples taken for each subject.
The fasting serum glucose concentrations were higher both in the alcoholics
with liver disease and in the patients with non-alcoholic liver disease when
compared with the normal volunteers (p<0.01). The patients with non-alcoholic
liver disease had higher mean fasting gastrin concentrations than either the
alcoholics with liver disease (p<0.005) or the normal controls (p<.0.05). The
patients with non-alcoholic liver disease had higher fasting plasma insulin
concentrations than either the normal volunteers (p<0.05) or the alcoholics with
or without liver disease (p<0.05).
The patients with alcoholic liver disease had higher fasting plasma PP concen-
trations than either the subjects with non-alcoholic liver disease (p<0.05) or the
normal volunteers (p<0.05). The alcoholics with liver disease had lower fasting
plasma GIP concentrations than the normal volunteers (p<0.05).
There were no significant differences noted in fasting plasma N-terminal
glucagon or C-terminal concentrations in any of the groups. The patients with
non-alcoholic liver disease had higher fasting plasma VIP concentrations than
either the alcoholics with liver disease (p<0.05) or normal controls (p<0.005).
Post-prandial changes in gastroenteropancreatic hormones andglucose
There were significantly higher post-prandial serum glucose concentrations
at 120 minutes in the alcoholics with liver disease (6.6 SE ± 0.8 mmol/l)
than in the alcoholics without liver disease (4.9 ± 0.4 mmol/l, the patients
with non-alcoholic liver disease (5.4 ± 0.8 mmol/l, or the normal controls
(4.3 ± 0.2 mmol/l).
There were significantly lower post-prandial insulin concentrations in the
alcoholics with liver disease (40 ± 8mU/l) than in either the alcoholics without
liver disease at 45 minutes (69 ± 7mU/1), the patients with non-alcoholic liver
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disease at 60 minutes (42 ± 9mU/I and 87 ± 19mU/l) or the normal volunteers
at 30 minutes (32 ± 6mU/I and 68 ± 8mU/1).
There were lower plasma gastrin concentrations in the alcoholics with liver
disease than in the patients with non-alcoholic liver disease at 45 minutes
(49 ± 20ng/l and 160 ± 60ng/l, respectively) and at 60 minutes (54 ± 22ng/l
and 140 ± 61 ng/l). There was no significant difference in post-prandial plasma
gastrin at the recorded times between the alcoholics with and without liver
disease and the normal volunteers. There were no significant differences in post-
prandial plasma concentrations of PP or GIP, between any of the groups.
DISCUSSION
In this paper alcoholics were defined as patients who have consumed more than
150g alcohol per day (approximately 15 measures or two bottles ofwine) for five
or more years before inclusion in the study. While this definition is arbitrary, most
authorities would agree that the patients included were likely to have dependence
or harm as a result oftheir alcohol consumption. The slightly higher mean alcohol
consumption in the alcoholics without liver disease than the group with liver
disease was not significant, and may be related to a decreased ability in the latter
group to metabolise alcohol.
There was evidence of post-prandial glucose intolerance in both groups with liver
disease in keeping with previous studies.3 This may be due to a combination of
hepatic resistance to the action of insulin and the porto-systemic shunting of both
the carbohydrate load and insulin.34 As there was no elevation of the fasting
serum glucose concentration in the alcoholics without liver disease, the present
data suggests that liver disease was responsible for glucose intolerance noted in
alcoholism. Although the patients with non-alcoholic liver disease had fasting
hyperinsulinism, plasma insulin concentrations in either alcoholic group were
similar to that recorded in the normal volunteers and these findings are in
agreement with previous work.4,5 There is a suggestion in the present study that
the elevation of fasting plasma insulin concentration is associated with the
presence of liver disease (in the subjects with non-alcoholic liver disease) rather
than the presence of alcoholism itself as has previously been reported.6 There
was a lower post-prandial insulin response in patients with alcoholic liver disease
compared with normal controls, which contrasts with the post-prandial hyper-
insulinism associated with alcoholic liver disease in previous studies.6 These
differences could possibly be related to the severity of the liver disease, patients
with more severe liver disease having decreased hepatic metabolism of insulin
and increased porto-systemic shunting of insulin.
The fasting and post-prandial plasma gastrin concentrations were elevated in the
patients with non-alcoholic liver disease, confirming previous work in patients
with cirrhosis.7 Alcoholism, either with or without liver disease, did not affect
plasma gastrin concentration.
The fasting plasma PP concentration in both groups with liver disease was higher
than in thenormal controls, in agreement with previous reportsin both alcoholics9
and subjects with liver failure.8 PP is known to be a strong inhibitor of pancreatic
secretion.9 Because up to 40% of alcoholics may have pancreatic exocrine
insufficiency, even in the absence of clinical evidence of chronic pancreatitis,'0
some authors have suggested that pancreatic insufficiency may be a result of
elevation of PP concentrations.5 However, there was no elevation in PP in the
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alcoholic subjects without liver disease, and therefore liver disease rather than the
presence of alcoholism may be the predominant influence in increasing the
fasting plasma concentrations of PP.
The reduction in fasting plasma GIP in alcoholics with liver disease when
compared with the normal volunteers was not observed in the subjects with non-
alcoholic liver disease, suggesting that alcoholism in combination with liver
disease reduces GIP concentrations. While the significance of this in unclear, GIP
is known to inhibit gastric acid production in animal experiments" 1 and therefore
the present reduction in GIP may play a role in the hyperacidity associated with
alcohol ingestion.'12 13
N-terminal glucagon release is thought to be a measure of both enteroglucagon
and pancreatic glucagon, and C-terminal glucagon is thought to be a measure of
pancreatic glucagon. There were no differences noted in either N- or C-terminal
glucagon concentrations as a consequence of either alcoholism or liver disease
which is in agreement with previous studies.5
An elevation of fasting plasma VIP concentrations in patients with non-alcoholic
liver disease compared with controls has been shown previously.14 15, 16
Alcoholism without liver disease, however, had no apparent effect on fasting
plasma VIP concentrations. It has been suggested that the elevation of VIP in
subjects with liver disease is due to porto-systemic shunting, and this elevation in
VIP, while small, may nevertheless be related to some of the features of liver
disease including diarrhoea and cutaneous vascular changes.
The purpose of this study was to clarify the changes in gastroenteropancreatic
hormones related either to chronic alcohol ingestion or to liver disease. There
was no difference in fasting or post-prandial hormone release in the alcoholic
group without liver disease compared with that found in the normal volunteers,
indicating that alcoholism without hepatic complications does not influence
gastroenteropancreatic hormone release.
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